Experiences with

Small cell lung cancer

my daughter has above - does anyone have experience of this? Thanks A worried Mum

cell lung cancer (NSCLC) following complete tumour resection.”

Alectinib hydrochloride (Alecensa) will shortly be assessed by the Scottish Medicines Consortium (SMC) for use in NHS Scotland The indication this medicine will be assessed under is: “Monotherapy as adjuvant treatment for adult patients with Stage IB (tumours ≥ 4cm) to IIIA (7th edition of the UICC/

Osimertinib (Tagrisso) in combination with pemetrexed and platinum-based chemotherapy will shortly be assessed by the Scottish Medicines Consortium (SMC) for use in NHS Scotland The indication this medicine will be assessed under is for the first-line treatment of adult patients with advanced

Have you had surgery or radiotherapy for early-stage non-small cell lung cancer within the past year? Did you have you cancer treatment in England? Are you available to take part in a 1-hour interview online, by phone or in person?

Read the full FDA announcement: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-durvalumab-limited-stage-small-cell-lung-cancer

Read the full FDA announcement here:https://go2.org/blog/fda-approves-imdelltra-tarlatamab-dlle-for-extensive-stage-small-cell-lung-cancer/

Join us for a conversation on how new targeted therapies and a greater understanding of tumor biology have advanced treatments for EGFR-mutated non-small cell lung cancer (NSCLC). First-generation targeted therapy drugs outperformed traditional chemotherapy, but new mutations led to resistance.

I’m getting near the end of chemo-radiotherapy. It’s the second time I’ve had to through it in the last five years - the last time was for anal cancer - and nothing really prepared me for how tough it has been. One more chemo to go (cisplatin and etoposide) and I’m starting to think about how best

In late-stage trials for non-small-cell lung cancer, it nearly doubled the time patients lived without the disease worsening—to 11.1 months, compared with 5.8 months for Keytruda..... From [i]The Economist[/i]

In 2022, much to my shock, I was diagnosed with small cell lung cancer (SCLC). At the time, I had no idea what small cell lung cancer meant. Naively, I assumed that “small” meant insignificant. It was not insignificant.

I have been getting phone calls from the pulmonologist office that originally diagnosed me in April 2024 with small cell lung cancer. They want to schedule an appointment for a breathing test. When I told them I was on prednisone for pneumonitis they seems confused.

My Mum passed away at the beginning of September from extensive stage small cell lung cancer. It all happened so quickly. She went to the GP at the end of June for the first time, and was told she had a chest infection.

Developed by Phanes Therapeutics, it is aimed at aggressive malignancies such as small cell lung cancer (SCLC) and neuroendocrine prostate cancer (NEPC).

The last biopsy I had said it was all breast cancer. This biopsy says it's small cell lung cancer (yes I am a smoker). I have been crying a lot and I know this cancer is aggressive and fast growing. But get this this one tumor I have had since the beginning of being diagnosed with breast cancer.

LY4052031 is an investigational antibody-drug conjugate (ADC) targeting Nectin-4, a protein overexpressed in cancers like prostate, bladder, breast, non-small cell lung cancer, and gastric cancers. Nectin-4’s low expression in normal tissues makes it an ideal target for precision therapies.

Thought this was as worth sharing here https://www.cancer.gov/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival?cid=eb_govdel_cancerinfo

The last biopsy I had said it was all breast cancer. This biopsy says it's small cell lung cancer (yes I am a smoker and it's rare in nonsmokers to get it but women can - only though about 2 -3%). I have been crying a lot and I know this cancer is aggressive and fast growing.

https://www.cancer.gov/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival?cid=eb_govdel_cancerinfo

Read about Jim's story here: https://go2.org/blog/a-veterans-story-with-small-cell-lung-cancer-sclc/